Answers are grounded in this paper and cite their sources.
Randomized trial reveals superior bowel preparation efficacy with linaclotide over senna, highlighting a promising regimen for patients at high risk of inadequate cleansing.
The linaclotide regimen was superior to the senna regimen reagrding BP efficacy without reducing tolerability. It can be a promising new option for BP, especially in patients at a high risk of inadequate BP.
No takes yet. Share an insight, caveat, or question.
Maeda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: